{"transactions":[{"id":4214203,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":173318,"kind":"person","name":"Fox Dale","position":1,"cik":"0001617902","reported_name":"Fox Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2017-09-08T18:28:08.000Z","date":"2017-09-06","kind":"grant","acquired":true,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was originally granted on January 3, 2017 and vests and become exercisable in four (4) equal installments on each March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017."}],"balance_after":12000,"derivative":{"exercise_price":0.67,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001513162-17-000255","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000255/primary_doc.xml","form_type":"4"}},{"id":4214202,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":173318,"kind":"person","name":"Fox Dale","position":1,"cik":"0001617902","reported_name":"Fox Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2017-09-08T18:28:08.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was originally granted on January 3, 2017 and vests and become exercisable in four (4) equal installments on each March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017."}],"balance_after":0,"derivative":{"exercise_price":5.3,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001513162-17-000255","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000255/primary_doc.xml","form_type":"4"}},{"id":4214201,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":173318,"kind":"person","name":"Fox Dale","position":1,"cik":"0001617902","reported_name":"Fox Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2017-09-08T18:28:08.000Z","date":"2017-09-06","kind":"grant","acquired":true,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was originally granted on February 18, 2016 and vested in four (4) equal installments on each of March 31, 2016, June 30, 2016, September 30, 2016 and December 31, 2016."}],"balance_after":12000,"derivative":{"exercise_price":0.67,"expiration_date":"2026-01-14","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001513162-17-000255","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000255/primary_doc.xml","form_type":"4"}},{"id":4214200,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":173318,"kind":"person","name":"Fox Dale","position":1,"cik":"0001617902","reported_name":"Fox Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2017-09-08T18:28:08.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was originally granted on February 18, 2016 and vested in four (4) equal installments on each of March 31, 2016, June 30, 2016, September 30, 2016 and December 31, 2016."}],"balance_after":0,"derivative":{"exercise_price":2.92,"expiration_date":"2026-01-14","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001513162-17-000255","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000255/primary_doc.xml","form_type":"4"}},{"id":4214199,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":173318,"kind":"person","name":"Fox Dale","position":1,"cik":"0001617902","reported_name":"Fox Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2017-09-08T18:28:08.000Z","date":"2017-09-06","kind":"grant","acquired":true,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was originally granted on January 2, 2015 and vested in four (4) equal installments on each of March 31, 2015, June 30, 2015, September 30, 2015 and December 31, 2015."}],"balance_after":12000,"derivative":{"exercise_price":0.67,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001513162-17-000255","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000255/primary_doc.xml","form_type":"4"}},{"id":4214198,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":173318,"kind":"person","name":"Fox Dale","position":1,"cik":"0001617902","reported_name":"Fox Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2017-09-08T18:28:08.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was originally granted on January 2, 2015 and vested in four (4) equal installments on each of March 31, 2015, June 30, 2015, September 30, 2015 and December 31, 2015."}],"balance_after":0,"derivative":{"exercise_price":2.575,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001513162-17-000255","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000255/primary_doc.xml","form_type":"4"}},{"id":4214197,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":173318,"kind":"person","name":"Fox Dale","position":1,"cik":"0001617902","reported_name":"Fox Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2017-09-08T18:28:08.000Z","date":"2017-09-06","kind":"grant","acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was originally granted on August 8, 2014 and vested 50% on September 30, 2016 and 50% on December 31, 2016."}],"balance_after":6000,"derivative":{"exercise_price":0.67,"expiration_date":"2024-08-08","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001513162-17-000255","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000255/primary_doc.xml","form_type":"4"}},{"id":4214196,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":173318,"kind":"person","name":"Fox Dale","position":1,"cik":"0001617902","reported_name":"Fox Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2017-09-08T18:28:08.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was originally granted on August 8, 2014 and vested 50% on September 30, 2016 and 50% on December 31, 2016."}],"balance_after":0,"derivative":{"exercise_price":2.575,"expiration_date":"2024-08-08","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001513162-17-000255","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000255/primary_doc.xml","form_type":"4"}},{"id":4493480,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":173318,"kind":"person","name":"Fox Dale","position":1,"cik":"0001617902","reported_name":"Fox Dale","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-01-11T10:53:41.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in four (4) equal installments on each March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017"}],"balance_after":12000,"derivative":{"exercise_price":5.3,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001513162-17-000017","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000017/primary_doc.xml","form_type":"4"}}]}